Advanced Proteome Therapeutics Corporation reported earnings results for the second quarter and six months ended January 31, 2023. For the second quarter, the company reported net loss was USD 0.277989 million compared to net income of USD 0.627774 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.02 a year ago.
For the six months, net loss was USD 0.487701 million compared to net income of USD 1.3 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.04 a year ago.